123 related articles for article (PubMed ID: 1614182)
1. [Pilot study of amiloride inhalation in children with cystic fibrosis].
Riedler J; Huttegger I
Klin Padiatr; 1992; 204(3):158-62. PubMed ID: 1614182
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
Knowles MR; Church NL; Waltner WE; Yankaskas JR; Gilligan P; King M; Edwards LJ; Helms RW; Boucher RC
N Engl J Med; 1990 Apr; 322(17):1189-94. PubMed ID: 2157983
[TBL] [Abstract][Full Text] [Related]
3. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.
App EM; King M; Helfesrieder R; Köhler D; Matthys H
Am Rev Respir Dis; 1990 Mar; 141(3):605-12. PubMed ID: 2310093
[TBL] [Abstract][Full Text] [Related]
4. Aerosolized amiloride: dose effect on nasal bioelectric properties, pharmacokinetics, and effect on sputum expectoration in patients with cystic fibrosis.
Hofmann T; Senier I; Bittner P; Hüls G; Schwandt HJ; Lindemann H
J Aerosol Med; 1997; 10(2):147-58. PubMed ID: 10168532
[TBL] [Abstract][Full Text] [Related]
5. Amiloride inhalation therapy in cystic fibrosis. Influence on ion content, hydration, and rheology of sputum.
Tomkiewicz RP; App EM; Zayas JG; Ramirez O; Church N; Boucher RC; Knowles MR; King M
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1002-7. PubMed ID: 8214916
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis.
Jones KM; Liao E; Hohneker K; Turpin S; Henry MM; Selinger K; Hsyu PH; Boucher RC; Knowles MR; Dukes GE
Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317
[TBL] [Abstract][Full Text] [Related]
7. Increasing concentration of inhaled saline with or without amiloride: effect on mucociliary clearance in normal subjects.
Sood N; Bennett WD; Zeman K; Brown J; Foy C; Boucher RC; Knowles MR
Am J Respir Crit Care Med; 2003 Jan; 167(2):158-63. PubMed ID: 12411282
[TBL] [Abstract][Full Text] [Related]
8. No added benefit from nebulized amiloride in patients with cystic fibrosis.
Graham A; Hasani A; Alton EW; Martin GP; Marriott C; Hodson ME; Clarke SW; Geddes DM
Eur Respir J; 1993 Oct; 6(9):1243-8. PubMed ID: 8287938
[TBL] [Abstract][Full Text] [Related]
9. Effect of uridine 5'-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis.
Bennett WD; Olivier KN; Zeman KL; Hohneker KW; Boucher RC; Knowles MR
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1796-801. PubMed ID: 8665037
[TBL] [Abstract][Full Text] [Related]
10. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
[TBL] [Abstract][Full Text] [Related]
11. Mucus clearance and lung function in cystic fibrosis with hypertonic saline.
Donaldson SH; Bennett WD; Zeman KL; Knowles MR; Tarran R; Boucher RC
N Engl J Med; 2006 Jan; 354(3):241-50. PubMed ID: 16421365
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis.
Deterding R; Retsch-Bogart G; Milgram L; Gibson R; Daines C; Zeitlin PL; Milla C; Marshall B; Lavange L; Engels J; Mathews D; Gorden J; Schaberg A; Williams J; Ramsey B;
Pediatr Pulmonol; 2005 Apr; 39(4):339-48. PubMed ID: 15704203
[TBL] [Abstract][Full Text] [Related]
13. Chest physiotherapy with positive airway pressure: a pilot study of short-term effects on sputum clearance in patients with cystic fibrosis and severe airway obstruction.
Placidi G; Cornacchia M; Polese G; Zanolla L; Assael BM; Braggion C
Respir Care; 2006 Oct; 51(10):1145-53. PubMed ID: 17005060
[TBL] [Abstract][Full Text] [Related]
14. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.
Subbarao P; Balkovec S; Solomon M; Ratjen F
Pediatr Pulmonol; 2007 May; 42(5):471-6. PubMed ID: 17436328
[TBL] [Abstract][Full Text] [Related]
15. [Elimination of secretions in CF patients under amiloride inhalation].
Lindemann H; Becker T; Bittner P; Boldt A; Hofmann T; Schwandt HJ
Pneumologie; 1990 Oct; 44(10):1148-50. PubMed ID: 2281055
[TBL] [Abstract][Full Text] [Related]
16. [Amiloride inhalation therapy in mucoviscidosis].
Lindemann H
Monatsschr Kinderheilkd; 1993 May; 141(5):392-4. PubMed ID: 8326957
[TBL] [Abstract][Full Text] [Related]
17. Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial.
De Boeck K; Haarman E; Hull J; Lands LC; Moeller A; Munck A; Riethmüller J; Tiddens H; Volpi S; Leadbetter J; Charlton B; Malfroot A;
J Cyst Fibros; 2017 May; 16(3):380-387. PubMed ID: 28258928
[TBL] [Abstract][Full Text] [Related]
18. Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study.
Aitken ML; Bellon G; De Boeck K; Flume PA; Fox HG; Geller DE; Haarman EG; Hebestreit HU; Lapey A; Schou IM; Zuckerman JB; Charlton B;
Am J Respir Crit Care Med; 2012 Mar; 185(6):645-52. PubMed ID: 22198974
[TBL] [Abstract][Full Text] [Related]
19. Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study.
Westerman EM; Le Brun PP; Touw DJ; Frijlink HW; Heijerman HG
J Cyst Fibros; 2004 Mar; 3(1):23-8. PubMed ID: 15463883
[TBL] [Abstract][Full Text] [Related]
20. Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects.
Middleton PG; Geddes DM; Alton EW
Thorax; 1993 Aug; 48(8):812-6. PubMed ID: 8211871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
